Hepatitis B Booster Study in Adolescence

PHASE4CompletedINTERVENTIONAL
Enrollment

359

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

May 31, 2016

Conditions
Hepatitis B
Interventions
BIOLOGICAL

EngerixB, GlaxoSmithKline Vaccines

Trial Locations (1)

V5Z 4H4

Vaccine Evaluation Center (University of BC at Children's Hospital), Vancouver

All Listed Sponsors
collaborator

Canadian Immunization Research Network

NETWORK

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of British Columbia

OTHER

NCT02169674 - Hepatitis B Booster Study in Adolescence | Biotech Hunter | Biotech Hunter